HMG (0.15 mg / 75 IU Vial) Dosage Protocol

Plan based on a 12–16 week research schedule with three administrations per week.

• HMG Vials (75 IU / 0.15 mg each):
  • 12 weeks: 36 vials
  • 16 weeks: 48 vials
• Sterile 1 mL Administration Syringes:
  • 12 weeks: 36 syringes
  • 16 weeks: 48 syringes
• Sterile 0.9% Sodium Chloride, USP:
  • 12 weeks: 36 single-use 1 mL diluent units
  • 16 weeks: 48 single-use 1 mL diluent units
• Alcohol Swabs:
  • 12 weeks: 72 swabs, 1 box
  • 16 weeks: 96 swabs, 1 box

Safe disposal: Place used needles and syringes in a puncture-resistant sharps container.

View Supplier

View Supplier

• Reconstitute: Add 1.0 mL sterile 0.9% Sodium Chloride, USP → 75 IU/mL concentration.
• Typical protocol: 75 IU three times weekly for 12–16 weeks, usually combined with hCG therapy.
• Volume consideration: Each 75 IU dose = 1.0 mL, using a single 1 mL administration volume.
• Storage: Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F); after reconstitution, use promptly or refrigerate and use within a few days.

Human Menopausal Gonadotropin (HMG) is a purified gonadotropin preparation containing equal amounts of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity^[2]. In males, HMG is used alongside hCG to stimulate spermatogenesis in cases of hypogonadotropic hypogonadism or infertility^[3][4]. This educational protocol presents a thrice-weekly subcutaneous approach for male fertility support.

Concise summary of the thrice-weekly male fertility regimen.

• Goal: Stimulate spermatogenesis in males with hypogonadotropic hypogonadism or infertility^[3][4].
• Schedule: Subcutaneous injections three times weekly for minimum 12 weeks (extend to 16 weeks if needed)^[7].
• Dose: 75 IU (0.15 mg) per injection, typically combined with hCG therapy.
• Reconstitution: 1.0 mL per 75 IU vial (75 IU/mL) for calculation convenience.
• Storage: Lyophilized refrigerated; reconstituted solution used promptly or within days when refrigerated.

Standard male fertility support approach.

• Dose: 75 IU three times per week (e.g., Monday, Wednesday, Friday).
• Combination Therapy: Usually administered alongside hCG (2–3 times weekly) to support testosterone and maximize spermatogenesis.
• Cycle Length: Minimum 12 weeks; may extend to 16 weeks based on response^[7].
• Route: Subcutaneous injection into fatty tissue (abdomen, thigh, or upper arm)^[8].
• Timing: Maintain consistent injection days; rotate sites with each injection.

Proper storage maintains HMG stability and potency.

• Lyophilized (unopened): Store at 2–8 °C (35.6–46.4 °F) away from light; stable at controlled room temperature up to 25 °C (77 °F)^[9].
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); for best potency use promptly (official guidance recommends immediate use with plain diluent)^[9].
• Protect from light at all times; discard any unused solution if not used within recommended timeframe.

Practical considerations for safe and effective administration.

• HMG therapy typically requires concurrent hCG administration for optimal results in males.
• Use new sterile syringes for each injection; dispose in a sharps container^[10].
• Rotate injection sites (abdomen, thighs, upper arms) at least 1 inch apart to prevent lipohypertrophy or irritation^[11].
• Monitor semen parameters and hormone levels throughout therapy to assess response.
• Clinical response typically requires at least 12 weeks; spermatogenesis may take 3–6 months to fully develop^[7].

HMG provides both FSH and LH activity in a 1:1 ratio, derived from purified human menopausal urine^[2]. In males with hypogonadotropic hypogonadism, FSH stimulation is essential for spermatogenesis (sperm production)^[3]. When hCG alone fails to induce adequate sperm production, adding HMG provides the necessary FSH activity to support testicular function and fertility. Clinical studies demonstrate that HMG combined with hCG significantly improves sperm parameters including motility, morphology, and concentration, with enhanced pregnancy rates in treated couples^[7][12].

Observations from clinical fertility literature.

Potential Benefits:

• Stimulates spermatogenesis in men with hypogonadotropic hypogonadism or secondary infertility^[3][4].
• Improves sperm motility, morphology, and concentration when combined with hCG therapy^[7][12].
• Significantly increases pregnancy rates in couples undergoing fertility treatment^[7].
• Supports normal testicular function and hormone production.

Potential Side Effects:

• Injection site reactions (redness, swelling, mild pain)^[8].
• Headache, fatigue, or mood changes (uncommon).
• Gynecomastia (breast tissue development) due to hormonal stimulation.
• Overstimulation effects if dosing is excessive (rare in males with proper monitoring).
• Allergic reactions (rare); discontinue if hypersensitivity occurs.

Complementary strategies to support fertility outcomes.

• Maintain healthy body weight and balanced nutrition rich in antioxidants (zinc, selenium, vitamin C, vitamin E).
• Avoid excessive heat exposure to testes (hot tubs, saunas, tight clothing).
• Limit alcohol consumption and avoid tobacco and recreational drugs.
• Manage stress through adequate sleep, exercise, and relaxation techniques.
• Regular moderate exercise supports hormonal balance (avoid excessive endurance training).
• Consider coenzyme Q10, L-carnitine, or other evidence-based supplements after consultation.

Proper subcutaneous injection technique for HMG administration^[8][10][11].

1. Wash hands thoroughly and gather supplies on a clean surface.
2. Clean the vial stopper with an alcohol swab and allow to dry.
3. Draw up the prescribed dose using a sterile syringe (1 mL capacity for the full 75 IU dose).
4. Select an injection site with adequate subcutaneous fat (lower abdomen at least 2 inches from navel, outer thigh, or upper arm).
5. Clean the injection site with a fresh alcohol swab; let dry completely.
6. Pinch about an inch of skin to create a fold of subcutaneous tissue.
7. Insert needle at a 90° angle (or 45° if very little subcutaneous fat) into the tissue^[10][11].
8. Release the pinch and slowly inject the medication over several seconds.
9. Withdraw the needle smoothly and apply gentle pressure with sterile gauze (do not rub the site).
10. Dispose of used syringe immediately in a sharps container^[10].
11. Rotate injection sites with each administration, maintaining at least 1 inch spacing from previous sites^[11].

We recommend Pure Lab Peptides for high-purity HMG (75 IU / 0.15 mg).

Shop at Pure Lab Peptides

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. HMG therapy should only be undertaken under the supervision of a qualified healthcare provider with appropriate monitoring of hormone levels and semen parameters. For research use only. Not intended for human consumption.

• 2
  
  Menopur® (Menotropins) Product Monograph
  — Human menopausal gonadotropin for subcutaneous administration; each vial contains 75 IU FSH + 75 IU LH activity

  View Source
• 3
  
  ASRM Practice Committee 2020 – Gonadotropin Use for Ovulation Induction
  — Clinical guidance on gonadotropin therapy; low-dose protocols (37.5–75 IU) with careful monitoring

  View Source
• 4
  
  ASRM Patient Fact Sheet – Medications for Inducing Ovulation
  — Typical gonadotropin protocols: 75–150 IU injected daily for approximately 7–12 days; course may extend if ovaries respond slowly

  View Source
• 7
  
  International Journal of Reproductive BioMedicine (Iran JRM, 2014)
  — Randomized trial: HMG 75 IU subcutaneously three times weekly for 3 months significantly improved sperm motility and morphology; pregnancy rate 57% vs. control

  View Source
• 8
  
  DailyMed MENOPUR Label – Administration and Reconstitution
  — Subcutaneous administration for follicular stimulation; each 75 IU vial typically reconstituted in 1 mL diluent for 75 IU/mL concentration

  View Source
• 9
  
  DailyMed MENOPUR Label – Preparation and Storage
  — Lyophilized menotropin stable at room temperature (15–25 °C) away from light; reconstituted solution should be used immediately to ensure potency and sterility

  View Source
• 10
  
  MedlinePlus – Subcutaneous Injection Instructions
  — Use short, thin needle for SC injections; insert at 90° angle into pinched fatty tissue (45° if limited subcutaneous fat); do not reuse needles

  View Source
• 11
  
  MedlinePlus – Injection Site Rotation
  — Maintain skin health by alternating injection sites at least one inch apart; avoid areas with irritation, scars, or bruises

  View Source
• 12
  
  Reproductive Medicine and Biology (2018) – Gonadotropin Therapy for Male Infertility
  — Review of hCG and hMG combination therapy for hypogonadotropic hypogonadism; FSH supplementation critical for spermatogenesis when hCG monotherapy inadequate

  View Source
• 13
  
  Pure Lab Peptides
  — HMG 75 IU product page with quality documentation and batch testing information

  View Source

Explore the available research context, protocol variants or comparisons, and practical guides. When vial-size variants exist, they remain separate because vial strength, concentration, and syringe-unit calculations can differ. Related compounds and blends are comparisons only, not interchangeable.